╨╧рб▒с>■  46■   3                                                                                                                                                                                                                                                                                                                                                                                                                                                ье┴'` Ё┐Оbjbjы╚ы╚ 4ЙвЙвО       д(((((((<ДДДД Р<¤░░░░░░░░|~~~~~~$ hu╘в(░░░░░в((░░╖,,,░R(░(░|,░|,,((,░д р`vT8╩Д,|═0¤,I I,I(,P░░,░░░░░вв" ░░░¤░░░░<<<др д<<<р <<<((((((     DRUG DEVELOPMENT WITH BIO-BUSINESS (MSc/PgDip/PgCert) 57B2DBB1/61B2DBVX/62B2DBVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers in the development, use and knowledge of new and current drugs. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; regulatory affairs and the Business of Science including entrepreneurship. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and directed self-learning. The curriculum excludes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. There will be an introduction to the commercial, legal (intellectual property) and ethical aspects of todayТs bio-business world. Candidates shall be required to attend the following designated programme of courses: First Half-Session BT 5005 Introduction to Biobusiness (10 credit points) GS 50M1 Generic Skills (0 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5008 Molecular Pharmacology (20 credit points) MT 5010 Basic Skills Ц Induction (0 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Second Half-Session BT 5503 Basic Lab Skills (10 credit points) additional for students taking lab based research projects BT 5505 Advanced Bio-Business (10 credit points) MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to the final stage as an MSc candidate if they fail to achieve an appropriate standard in the above programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Final Stage MSc only MT 5506 Omics and research (5 credit points) MT 5810 Research Project (65 credit points) PgDip only MT 5809 Dissertation (20 credit points) Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The thesis/dissertation will be assessed and there may be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. QRk$ - Х Щ √  БФСЬЮж 5@НОЎщ▄Ў▄Ў▄Ў▄Ў╤Ў╤ЎщЎщЎ▄Ў═hVБh5>*OJQJ^Jh56БOJQJ]Б^Jh55БOJQJ\Б^Jh5OJQJ^JQR# $ Ф Х · √ Т У щ ъ ¤ ■ 5^Ш└Є%SАБХєчтттттттттт▌т╨╨╨╨╨╨╨╨╨╨ ДДД|№^ДД`Д|№gd5gd5gd5  ╞ 06$┬gd5  ╞ 0D%┬gd5О■ХЦ¤.Zб═╬РСЭЮз╘ 45МНОЄЄЄЄЄЄЄэЄЄЄЄЄЄЄЄЄЄэЄыgd5 ДДД|№^ДД`Д|№gd521Рh:pekt░В. ░╞A!░Ё"░Ё#РЁ$РЁ%░░┬░┬ Р─ЖЬJ`ё J 5Normal$a$CJOJQJ_HmH sH tH 8`8 5 Heading 2$@&>*>`> 5 Heading 3$d8 @&5БDA@Є бD Default Paragraph FontVi@є │V  Table Normal :V Ў4╓4╓ laЎ (k@Ї ┴(No List О     QR#$ФХ·√ТУщъ¤■5^Ш└Є%SАБХЦ¤.Zб═╬Р С Э Ю з ╘  4 5 М Н Р (@0А|с(@0А|сШ@0АюШ@0АюШ@0АюШ@0АюШ@0АюШ@0АюШ@0АюШ@0АюШ@0АюШ@0Аю@0АЩ2Ш@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0АаєШ@0Ааєh╦00АQR#$ФХ·√ТУщъ¤■5^Ш└Є%SАБХЦ¤.Zб═╬Р С Э Ю з ╘  4 5 М Н Р *@0ААА*@0АААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0АА@0ААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0ААА 00Н О ХО О (4МС!6Gп ┤   Р  Р 3Р Р х БA5┐ #6, DektVБdДГ(Л4mеф фсlЇ╙° @АН Н РЖ Н Н О `@  Unknown            GРЗz А Times New Roman5РАSymbol3&Р Зz А ArialYР CG TimesTimes New Roman"qИЁ╨h#У┘ж#У┘ж▀п ▀п БЁЁЁx┤ВВ24И И  2ГqЁ▄HP)Ё ?ф                     52  5DRUG DEVELOPMENT WITH BIO-BUSINESS (MSc/PgDip/PgCert)Lorraine GerrardLorraine Gerrard■ рЕЯЄ∙OhлС+'│┘0┤РШ╪ф ( DP p | ИФЬдмф8DRUG DEVELOPMENT WITH BIO-BUSINESS (MSc/PgDip/PgCert)Lorraine GerrardNormalLorraine Gerrard1Microsoft Office Word@@J1T8╩@J1T8╩▀п ■ ╒═╒Ь.УЧ+,∙о00 hpРШаи ░╕└╚ ╨ ф51cgИ ' 6DRUG DEVELOPMENT WITH BIO-BUSINESS (MSc/PgDip/PgCert) Title ■   ■    !"■   $%&'()*■   ,-./012■   ¤   5■   ■   ■                                                                                                                                                                                                                                                                                                   Root Entry         └F nyT8╩7АData             1Table    IWordDocument    4SummaryInformation(            #DocumentSummaryInformation8        +CompObj            q            ■                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ■       └FMicrosoft Office Word Document MSWordDocWord.Document.8Ї9▓q